Teclison
company
About
Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $5.90M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$5.90M
Teclison has raised a total of
$5.90M
in funding over 2 rounds. Their latest funding was raised on
Feb 14, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 14, 2022 | Series Unknown | $5.90M | 2 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Teclison is funded by 2 investors.
WTT Investment
and Nestor Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
